Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SMBS
Schwab Mortgage-Backed Securities ETF
SMBS
|
+$5.08B |
| 2 |
Schwab Municipal Bond ETF
SCMB
|
+$1.29B |
| 3 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$752M |
| 4 |
Microsoft
MSFT
|
+$699M |
| 5 |
NVIDIA
NVDA
|
+$578M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$4.9B |
| 2 |
Invesco FTSE RAFI US 1000 ETF
PRF
|
+$986M |
| 3 |
iShares National Muni Bond ETF
MUB
|
+$951M |
| 4 |
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
|
+$794M |
| 5 |
Schwab Fundamental International Small Company Index ETF
FNDC
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.55% |
| 2 | Financials | 11.83% |
| 3 | Healthcare | 9.33% |
| 4 | Consumer Discretionary | 9.25% |
| 5 | Industrials | 8.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLPR
3401
Clipper Realty
CLPR
$46.4M
| $140K | ﹤0.01% |
38,207
| – | – |
|
|
BRDG
3402
DELISTED
Bridge Investment Group
BRDG
| $140K | ﹤0.01% |
13,968
+560
| +4% | +$5.22K |
|
3403
Rhinebeck Bancorp
RBKB
$194M
| $133K | ﹤0.01% |
+11,327
| New | +$126K |
|
|
APLT
3404
DELISTED
Applied Therapeutics
APLT
| $126K | ﹤0.01% |
403,514
-229,015
| -36% | -$88.6K |
|
|
SHCO
3405
DELISTED
Soho House & Co
SHCO
| $124K | ﹤0.01% |
16,810
| – | – |
|
3406
Envela
ELA
$416M
| $122K | ﹤0.01% |
+20,011
| New | +$124K |
|
|
NXXT
3407
NextNRG Inc
NXXT
$46.6M
| $121K | ﹤0.01% |
+43,775
| New | +$134K |
|
3408
INmune Bio
INMB
$56.6M
| $120K | ﹤0.01% |
51,825
+10,505
| +25% | +$77.1K |
|
3409
Ispire Technology
ISPR
$97M
| $119K | ﹤0.01% |
46,552
+49
| +0.1% | +$136 |
|
3410
Sagimet Biosciences
SGMT
$586M
| $114K | ﹤0.01% |
15,000
| – | – |
|
3411
Unusual Machines
UMAC
$1.41B
| $107K | ﹤0.01% |
+12,500
| New | +$78.8K |
|
3412
LanzaTech
LNZA
$69.3M
| $106K | ﹤0.01% |
3,911
-2,621
| -40% | -$64.3K |
|
|
MRDN
3413
Meridian Holdings Inc
MRDN
$170M
| $106K | ﹤0.01% |
5,195
+587
| +13% | +$12.8K |
|
3414
374Water
SCWO
$38.7M
| $104K | ﹤0.01% |
32,222
-14,141
| -31% | -$47.5K |
|
|
CTNM
3415
Contineum Therapeutics
CTNM
$550M
| $103K | ﹤0.01% |
26,039
-25,163
| -49% | -$109K |
|
|
IGMS
3416
DELISTED
IGM Biosciences
IGMS
| $100K | ﹤0.01% |
89,705
-35,909
| -29% | -$43.9K |
|
3417
Tevogen Inc. Common Stock
TVGN
$26.2M
| $95.6K | ﹤0.01% |
1,530
+537
| +54% | +$30.6K |
|
3418
MediciNova
MNOV
$65.5M
| $93.7K | ﹤0.01% |
71,506
| – | – |
|
3419
Century Therapeutics
IPSC
$352M
| $91.3K | ﹤0.01% |
163,377
-107,443
| -40% | -$57.6K |
|
3420
Forafric Global
AFRI
$288M
| $91.3K | ﹤0.01% |
11,701
| – | – |
|
|
ACTU
3421
Actuate Therapeutics
ACTU
$23.7M
| $90.2K | ﹤0.01% |
+14,765
| New | +$129K |
|
3422
Spero Therapeutics
SPRO
$70.1M
| $82.8K | ﹤0.01% |
28,565
| – | – |
|
|
RAPT
3423
DELISTED
RAPT Therapeutics
RAPT
| $80K | ﹤0.01% |
10,000
-8,868
| -47% | -$67.6K |
|
3424
Cabaletta Bio
CABA
$455M
| $76.9K | ﹤0.01% |
50,621
-109,245
| -68% | -$170K |
|
3425
Ring Energy
REI
$354M
| $76.7K | ﹤0.01% |
96,575
-367,455
| -79% | -$311K |
|
Similar funds
Charles Schwab's Q2 2025 Portfolio in Review
As of Q2 2025, Charles Schwab held 3,631 positions worth $578B, up 8.5% from $533B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Charles Schwab's Q2 2025 filing shows 158 new, 2,252 increased, 1,020 reduced and 137 closed positions. Its largest new stake was Schwab Mortgage-Backed Securities ETF: 202,020,489 shares worth $5.15B. The largest sale was Vanguard Mortgage-Backed Securities ETF, an estimated $4.9B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2025 buy was Schwab Mortgage-Backed Securities ETF: 202,020,489 shares worth $5.15B.
- Charles Schwab added most to Schwab Municipal Bond ETF in Q2 2025, an estimated $1.29B increase.
- Charles Schwab's biggest Q2 2025 reduction was Vanguard Mortgage-Backed Securities ETF, cutting an estimated $4.9B.
- Charles Schwab fully exited Invesco FTSE RAFI US 1000 ETF in Q2 2025, selling an estimated $986M.
- Charles Schwab's ten largest holdings make up 23% of its $578B portfolio in Q2 2025.
- Charles Schwab opened 158 new positions and closed 137 in Q2 2025.
- Charles Schwab's portfolio value rose 8.5% quarter-over-quarter to $578B.
Based on Charles Schwab's 13F filing for Q2 2025, filed 12 Aug 2025.